Advertisement

Electrophysiologic Study including Electroanatomic Mapping

  • Domenico Corrado
  • James Daubert
  • Cristina Basso
  • Gianfranco Buja
  • Gaetano Thiene

Abstract

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited heart muscle disease characterized by specific right ventricular (RV) involvement and risk of arrhythmic sudden death [1, 2, 3]. Distinctive pathologic feature is RV myocardial atrophy with replacement by fibrofatty tissue [2, 3, 4, 5]. The condition was initially believed to be a developmental defect of the RV myocardium, leading to the original designation of “dysplasia” [1]; this concept has evolved over the last 25 years into the current perspective of a genetically determined cardiomyopathy [6, 7]. The estimated prevalence of the disease in the general population ranges from 1 in 2,000 to 1 in 5,000. It affects men more frequently than women, with an approximate ratio of 3∶1;. Clinical manifestations develop most often between the second and fourth decade of life and usually are related to ventricular tachycardia of RV origin or ventricular fibrillation leading to cardiac arrest, mostly in young people [2, 4, 5, 6].Ventricular arrhythmias often are worse during or immediately after exercise, and participation in competitive athletics has been associated with an increased risk for sudden death [2, 4, 5]. Later in the disease evolution, progression of RV muscle disease and left ventricular involvement may result in right or biventricular heart failure [8]. Clinical diagnosis of ARVC/D is often difficult due to the nonspecific nature of disease features and the broad spectrum of phenotypic manifestation, ranging from severe to concealed forms [9, 10, 11]. The first objective of management strategy is to assess arrhythmic risk and prevent sudden death. Therapeutic options include antiarrhythmic drugs, catheter ablation, and implantable cardioverter defibrillator (ICD) [12].

Keywords

Right Ventricular Ventricular Tachycardia Ventricular Cardiomyopathy Arrhythmogenic Right Ventricular Dysplasia Right Ventricular Free Wall 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Marcus FI, Fontaine G, Guiraudon G et al (1982) Right ventricular dysplasia: A report of 24 adult cases. Circulation 65:384–398PubMedGoogle Scholar
  2. 2.
    Thiene G, Nava A, Corrado D et al (1988) Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318:129–133PubMedCrossRefGoogle Scholar
  3. 3.
    Nava A, Rossi L, Thiene G (eds) (1997) Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Elsevier, AmsterdamGoogle Scholar
  4. 4.
    Basso C, Thiene G, Corrado D et al (1996) Arrhythmogenic right ventricular cardiomyopathy: Dysplasia, dystrophy or myocarditis? Circulation 94:983–991PubMedGoogle Scholar
  5. 5.
    Corrado D, Basso C, Thiene G et al (1997) Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: A multicenter study. J Am Coll Cardiol 30:1512–1520PubMedCrossRefGoogle Scholar
  6. 6.
    Nava A, Bauce B, Basso C et al (2000) Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 36:2226–2233PubMedCrossRefGoogle Scholar
  7. 7.
    Maron BJ, Towbin JA, Thiene G et al (2006) American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816PubMedCrossRefGoogle Scholar
  8. 8.
    Corrado D, Basso C, Thiene G (2000) Arrhythmogenic right ventricular cardiomyopathy: Diagnosis, prognosis, and treatment. Heart 83:588–595PubMedCrossRefGoogle Scholar
  9. 9.
    McKenna WJ, Thiene G, Nava A et al (1994) Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 71:215–218PubMedCrossRefGoogle Scholar
  10. 10.
    Corrado D, Fontaine G, Marcus FI et al (2000) Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Need for an international registry. Circulation 101:e101–e106PubMedGoogle Scholar
  11. 11.
    Corrado D, Thiene G (2004) Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Is there a single gold standard test? J Cardiovasc Electrophysiol 15:307–309PubMedCrossRefGoogle Scholar
  12. 12.
    Corrado D, Leoni L, Link MS et al (2003) Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 108:3084–3091PubMedCrossRefGoogle Scholar
  13. 13.
    Bluemke DA, Krupinski EA, Ovitt T et al (2003) MR imaging of arrhythmogenic right ventricular cardiomyopathy: Morphologic findings and interobserver reliability. Cardiology 99:153–162PubMedCrossRefGoogle Scholar
  14. 14.
    Bomma C, Rutberg J, Tandri H et al (2004) Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol 15:300–306PubMedCrossRefGoogle Scholar
  15. 15.
    Angelini A, Thiene G, Boffa GM et al (1993) Endomyocardia1 biopsy in right ventricular cardiomyopathy. Int J Cardiol 40:273–282PubMedCrossRefGoogle Scholar
  16. 16.
    Angelini A, Basso C, Nava A, Thiene G (1996) Endomyocardia1 biopsy in arrhythmogenic right ventricular cardiomyopathy. Am Heart J 132:203–206PubMedCrossRefGoogle Scholar
  17. 17.
    Corrado D, Thiene G (2006) Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Clinical impact of molecular genetic studies. Circulation 113:1634–1637PubMedCrossRefGoogle Scholar
  18. 18.
    Klein H, Karp RB, Kouchousus NT et al (1982) Intraoperative electrophysiologic mapping of the ventricles during sinus rhythm in patients with a previous myocardial infarction. Identification of the electrophysiologic substrate of ventricular arrhythmia. Circulation 66:847–854PubMedGoogle Scholar
  19. 19.
    Cassidy DM, Vassallo JA, Miller JM et al (1986) Endocardial catheter mapping in patients in sinus rhythm: Relationship to underlying heart disease and ventricular arrhythmias. Circulation 73:645–652PubMedGoogle Scholar
  20. 20.
    Gepstein L, Goldin A, Lessick J et al (1998) Electromechanical characterization of chronic myocardial infarction in the canine coronary occlusion model. Circulation 98:2055–2064PubMedGoogle Scholar
  21. 21.
    Kornowski R, Hong MK, Gepstein L et al (1998) Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation 98:1116–1124PubMedGoogle Scholar
  22. 22.
    Smeets JLRM, Ben-Haim SA, Rodriguez LM et al (1998) New method for nonfluoroscopic endocardial mapping in humans: Accuracy assessment and first clinical results. Circulation 97:2426–2432PubMedGoogle Scholar
  23. 23.
    Callans DJ, Ren JF, Michele J et al (1999) Electroanatomic left ventricular mapping in the porcine model of healed anterior myocardial infarction: Correlation with intracardiac echocardiography and pathological analysis. Circulation 100:1744–1750PubMedGoogle Scholar
  24. 24.
    Boulos M, Lashevsky I, Reisner S, Gepstein L (2001) Electroanatomical mapping of arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol 38:2020–2027PubMedCrossRefGoogle Scholar
  25. 25.
    Corrado D, Basso C, Leoni L et al (2005) Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 111:3042–3050PubMedCrossRefGoogle Scholar
  26. 26.
    Corrado D, Tokajuk B, Leoni L et al (2005) Differential diagnosis between idiopathic right ventricular ouflow tract tachycardia and arrhythmogenic right ventricular cardiomyopathy/displasia by 3-D electroanatomic voltage mapping. Eur Heart J 26:373 (abstract)CrossRefGoogle Scholar
  27. 27.
    Marchlinski FE, Callans DJ, Gottlieb CD, Zado E (2000) Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 101:1288–1296PubMedGoogle Scholar
  28. 28.
    Hsia HH, Callans DJ, Marchlinski FE (2003) Characterization of endocardial electrophysiologic substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation 108:704–710PubMedCrossRefGoogle Scholar
  29. 29.
    Thiene G, Basso C, Calabrese F et al (2000) Pathology and pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Herz 25:210–215PubMedCrossRefGoogle Scholar
  30. 30.
    McKoy G, Protonotarios N, Crosby A et al (2000) Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355:2119–2124PubMedCrossRefGoogle Scholar
  31. 31.
    Thiene G, Corrado D, Nava A et al (1991) Right ventricular cardiomyopathy: Is there evidence of an inflammatory aetiology? Eur Heart J 12:22–25PubMedGoogle Scholar
  32. 32.
    Lieberman EB, Hutchins GM, Herskowitz A et al (1991) Clinicopathologic description of myocarditis. J Am Coll Cardiol 18:1617–1626PubMedCrossRefGoogle Scholar
  33. 33.
    Feldman AM, McNamara D (2000) Myocarditis. N Engl J Med 343:1388–398PubMedCrossRefGoogle Scholar
  34. 34.
    Matsumori A, Kawai C (1980) Coxsackie virus B3 perimyocarditis in BALB/c mice: Experimental model of chronic perimyocarditis in the right ventricle. J Pathol 131:97–106PubMedCrossRefGoogle Scholar
  35. 35.
    Hisaoka T, Kawai S, Ohi H et al (1990) Two cases of chronic myocarditis mimicking arrhythmogenic right ventricular dysplasia. Heart Vessels 5:51–54Google Scholar
  36. 36.
    Hofmann R, Trappe HJ, Klein H, Kemnitz J (1993) Chronic (or healed) myocarditis mimicking arrhythmogenic right ventricular dysplasia. Eur Heart J 14:717–720PubMedGoogle Scholar
  37. 37.
    Chimenti C, Pieroni M, Maseri A, Frustaci A (2004) Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol 43:2305–2313PubMedCrossRefGoogle Scholar
  38. 38.
    Pinamonti B, Alberti E, Cigalotto A et al (1988) Echocardiographic findings in myocarditis. Am J Cardiol 62:285–91PubMedCrossRefGoogle Scholar
  39. 39.
    Dec GW, Fuster V (1994) Medical Progress: idiopathic dilated cardiomyopathy. N Engl J Med 331:1564–1575PubMedCrossRefGoogle Scholar
  40. 40.
    Fontaine G, Fontaliran F, Frank R (1998) Arrhythmogenic right ventricular cardiomyopathies: clinical forms and main differential diagnosis. Circulation 97:1532–1535PubMedGoogle Scholar
  41. 41.
    Hamid MS, Norman M, Quraishi A et al (2002) Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 40:1445–1450PubMedCrossRefGoogle Scholar
  42. 42.
    Fontaine G, Frank R, Tonet JL et al (1984) Arrhythmogenic right ventricular dysplasia: a clinical model for the study of chronic ventricular tachycardia. Jpn Circ J 48:515–538PubMedGoogle Scholar
  43. 43.
    Turrini P, Corrado D, Basso C et al (2001) Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation 103:3075–3080PubMedGoogle Scholar
  44. 44.
    Baxton AE, Waxman HL, Marchlinski FE et al (1983) Right ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation 68:917–927Google Scholar
  45. 45.
    Lerman BB, Stein K, Engelstein ED et al (1995) Mechanism of repetitive monomorphic ventricular tachycardia. Circulation 92:421–429PubMedGoogle Scholar
  46. 46.
    Lerman BB, Stein KM, Markowitz SM (1996) Idiopathic right ventricular outflow tract tachycardia: a clinical approach. PACE 19:2120–2137PubMedGoogle Scholar
  47. 47.
    Boulos M, Lashevsky I, Gepstein L (2005) Usefulness of electroanatomical mapping to differentiate between right ventricular outflow tract tachycardia and arrhythmogenic right ventricular dysplasia. Am J Cardiol 95:935–940PubMedCrossRefGoogle Scholar
  48. 48.
    Scognamiglio R, Fasoli G, Ponchia A et al (1990) Contrast and two-dimensional echocardiography in right ventricular dysplasia: comparison with biopsy.Cardiovasc Imag 2:17–21Google Scholar
  49. 49.
    Daubert JC, Descaves C, Foulgoc JL et al (1988) Critical analysis of cineangiographic criteria for diagnosis of arrhythmogenic right ventricular dysplasia. Am Heart J 115:448–454PubMedCrossRefGoogle Scholar
  50. 50.
    Indik JH, Dallas WJ, Ovitt T et al (2005) Do patients with right ventricular outflow tract ventricular arrhythmias have a normal right ventricular wall motion? A quantitative analysis compared to normal subjects. Cardiology 104:10–15PubMedCrossRefGoogle Scholar
  51. 51.
    Guiraudon GM, Thakur RK, Klein GJ et al (1994) Encircling endocardial cryoablation for ventricular tachycardia after myocardial infarction: experience with 33 patients. Am Heart J 128:982–989PubMedCrossRefGoogle Scholar
  52. 52.
    Ostermeyer J, Breithardt G, Borggrefe M et al (1984) Surgical treatment of ventricular tachycardias: complete versus partial encircling endocardial ventriculotomy. J Thorac Cardiovasc Surg 87:517–525PubMedGoogle Scholar
  53. 53.
    Marchlinski FE, Zado E, Dixit S et al (2004) Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation 110:2293–2298PubMedCrossRefGoogle Scholar
  54. 54.
    Verma A, Kilicaslan F, Schweikert RA et al (2005) Short-and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation 111:3209–3216PubMedCrossRefGoogle Scholar
  55. 55.
    Wichter T, Hindricks G, Kottkamp H et al (1997) Catheter ablation of ventricular tachycardia. In: A Nava, L Rossi, G Thiene (eds) Arrhythmogenic right ventricular cardiomyopatrhy/dysplasia. Elsevier Amsterdam, pp 376–391Google Scholar
  56. 56.
    Ellison KE, Friedman PL, Ganz LI et al (1998) Entrainment and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol 32: 724–728PubMedCrossRefGoogle Scholar
  57. 57.
    Wichter T, Paul M, Wollmann C et al (2004) Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: Single-center experience of long-term follow-up and complications in 60 patients. Circulation 109:1503–1508PubMedCrossRefGoogle Scholar
  58. 58.
    Roguin A, Bomma CS, Nasir K et al (2004) Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 43:1843–1852PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • Domenico Corrado
    • 1
  • James Daubert
    • 2
  • Cristina Basso
    • 3
  • Gianfranco Buja
    • 1
  • Gaetano Thiene
    • 3
  1. 1.Department of Cardiological, Thoracic and Vascular SciencesUniversity of PaduaItaly
  2. 2.Division of Cardiology, Department of Internal Medicine, Strong Memorial HospitalUniversity of RochesterRochesterUSA
  3. 3.Department of Medical Diagnostic SciencesUniversity of PaduaItaly

Personalised recommendations